Yang Xu

Dr. Yang Xu

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 August 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
ZYZhenkun Yang
Zhenkun Yang
SWShuang Wu
Shuang Wu
YLYuanjie Li
Yuanjie Li
HLHongyu Liu
Hongyu Liu
MZManlin Zhao
Manlin Zhao
Gregory LipGregory Lip
Gregory Lip
Background: Cardiovascular-kidney-metabolic syndrome (CKM) represents a multisystem condition involving obesity, diabetes, chronic kidney disease, and cardiovascular diseases. Frailty, as measured by the Frailty Index (FI), is linked to adverse outcomes, but its association with CKM severity and mortality remains unclear. This study aimed to evaluate the relationship between frailty status, CKM staging, and mortality risk. Methods: We analysed data from 19,407 adults aged ≥ 45 years from NHANES 1999–2018. Frailty status was assessed using a 49-item Frailty Index (FI) and categorised as robust (FI ≤ 0.08), pre-frail (0.08 < FI < 0.25), or frail (FI ≥ 0.25). CKM was staged from 1 to 4 based on established clinical criteria. Multinomial logistic regression assessed the association between frailty status and CKM staging. Cox proportional hazards models evaluated the associations between frailty status and all-cause, cardiovascular, and non-cardiovascular mortality among CKM patients. Results: A total of 19,407 participants (median [IQR] age: 63.00 [54.00–72.00] years, 50.77% male), with 19,089 CKM patients. Frail individuals exhibited significantly higher odds of being assigned to advanced CKM stages. Over a median follow-up of 8.4 years, 4794 participants died. Kaplan–Meier curves and restricted cubic spline analyses demonstrated a clear gradient in mortality risk across frailty categories. Compared with the robust group, pre-frail and frail individuals had significantly higher risks of all-cause (HR = 1.47 and 2.83, respectively), cardiovascular (HR = 1.71 and 3.78), and non-cardiovascular mortality (HR = 1.40 and 2.57). Conclusions: Frailty status demonstrated a significant association with CKM staging and mortality outcomes. Early identification of frailty may help guide risk stratification and inform tailored interventions for individuals with CKM.

8 October 2026 in Biomedicines
Verified
Journal Article
Open access
PDF file
XWXiaoyan Wang
Xiaoyan Wang
YXYang Xu
Yang Xu
CPChongzhe Pei
Chongzhe Pei
HZHongmei Zheng
Hongmei Zheng
HCHeng Cai
Heng Cai
The escalating global burden of cardiovascular disease (CVD) necessitates a deeper elucidation of the fundamental molecular mechanisms driving its pathogenesis. Aberrant immune activation, specifically sterile inflammation, is now recognized as a core hallmark of CVD, predominantly ignited by the pathological accumulation of damaged self-DNA. As the principal cytosolic DNA sensor, the cyclic GMP-AMP synthase (cGAS)–stimulator of interferon genes (STING) pathway has emerged as a crucial mechanistic nexus translating genomic distress into robust innate immune responses. Despite its paramount importance, a comprehensive integration of how DNA damage-induced cGAS-STING activation orchestrates cardiovascular immunology remains underexplored. In this review, we comprehensively synthesize the dynamic immunological landscape of CVD, with a specific focus on the critical interplay between DNA damage and sterile inflammation. We delineate the intricate molecular cascades of the cGAS-STING pathway across diverse cardiovascular pathologies and critically evaluate its role as a master amplifier of disease progression. Furthermore, we highlight the translational trajectory of targeting the cGAS-STING axis, emphasizing how deciphering this DNA damage-immune network provides a rational blueprint for developing precision immunomodulatory therapies in cardiovascular medicine.

20 October 2026 in International Journal for Vitamin and Nutrition Research
Verified
Journal Article
Open access
PDF file
YXYang Xu
Yang Xu
CPChongzhe Pei
Chongzhe Pei
HZHongmei Zheng
Hongmei Zheng
LXLi Xue
Li Xue
HLHongshi Li
Hongshi Li
HCHeng Cai
Heng Cai
Background: Patients remain at substantial residual cardiovascular risk despite standardized management of classical risk factors. These limitations in clinical practice have led to an exposome-based approach. Among environmental exposures, endocrine-disrupting chemicals (EDCs) have emerged as ubiquitous and insidious promoters of cardiometabolic disease. Objectives: This review critically examines chronic environmental exposure to EDCs and the role of these chemicals in cardiovascular injury. In addition, this review highlights how targeted dietary therapies can shift patient management from passive environmental avoidance toward active biological protections. Methods and Results: We review recent mechanistic advances and show that lipophilic EDCs can hijack host signaling networks even at very low exposure levels. These molecular alterations promote mitochondrial dysfunction and global epigenetic reprogramming, leading to proximal metabolic derangements, particularly adipose tissue inflammation, insulin resistance, and atherogenic dyslipidemia. The cardioprotective effects of dietary antioxidants and bioactive phytochemicals appear to arise from intracellular signaling crosstalk. These compounds activate the nuclear factor erythroid 2-related factor 2 (Nrf2) antioxidant pathway while inhibiting the nuclear factor kappa B (NF-κB) proinflammatory cascade, thereby reducing oxidative stress and endothelial inflammation. Bioactive compounds such as polyphenols, omega-3 fatty acids, and vitamin D may function as nutriepigenetic modulators that counter receptor toxicity and resolve vascular inflammation. Simultaneously, the gut microbiota–vascular axis may act as a biological filter. The Mediterranean diet provides one such holistic intervention by strengthening intestinal barrier function, improving short-chain fatty acid (SCFA) signaling, and reducing pro-atherogenic trimethylamine N-oxide (TMAO) production. Conclusions: EDC exposure disrupts metabolism and can lead to cardiovascular disease. Nutritional approaches targeting the vulnerable human–environment interface can become a proactive chemopreventive shield. Future preventive cardiology may require a significant shift toward precision dietary fortification with an exposome-level risk assessment.